Takashi Kanamori1,2, Masashi Sanada2, Masaki Ri1, Hiroo Ueno3, Dai Nishijima2, Takahiko Yasuda2, Sho Aoki1, Takashi Yoshida1, Shiori Kinoshita1, Tomoko Narita1, Asahi Ito1, Shigeru Kusumoto1, Yuta Masuda4, Nobuhiko Kobayashi5, Yusuke Shiozawa3,6, Kenichi Yoshida3, Masahiro Nakagawa3, Yasuhito Nannya3, Yuichi Shiraishi7, Kenichi Chiba7, Hiroko Tanaka7, Hirokazu Komatsu1, Satoru Miyano7, Hiroshi Handa4, Seishi Ogawa3, Shinsuke Iida1 (1.Department of Hematology and Oncology, Nagoya City University, Nagoya, Japan, 2.Clinical Research Center, Nagoya Medical Center,Nagoya,Japan, 3.Department of Pathology and Tumor Biology, Kyoto University,Kyoto,Japan, 4.Graduate School of Health Sciences, Gunma University,Maebashi,Japan, 5.Department of Medicine and Clinical Science, Gunma University,Maebashi,japan, 6.Department of.Pediatrics, Univ. of Tokyo,Tokyo,Japan, 7.Human Genome Center, Insti. of Med. Science, Univ. of Tokyo,Tokyo,Japan)
Session information
Oral Session
Oral Session 3-9A MM: Biology
Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.9 (Osaka International Convention Center, 10F 1008)
Chair: Yusuke Furukawa (Division of Stem Cell Regulation, Jichi Medical University, Japan)
【E】
Saki Watanabe1, Tsukasa Oda2, Yuko Kuroda1, Yuki Murakami1, Rei Ishihara1, Masanobu Sunaga1, Eiko Yamane1, Nobuhiko Kobayashi3, Yohei Osaki4, Takuma Ishizaki3, Hiroaki Shimizu3, Hiromi Koiso3, Hirono Iriuchishima5, Nanami Gotoh1, Tetsuhiro Kasamatsu1, Akihiko Yokohama5, Takayuki Saitoh1, Hirokazu Murakami1, Norifumi Tsukamoto4, Hiroshi Handa3 (1.Graduate School of Health Sciences, Gunma University, Gunma, Japan, 2.Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan, 3.Department of Hematology, Gunma University, Gunma, Japan, 4.Oncology Center, Gunma University Hospital, Gunma, Japan, 5.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan)
Yuki Murakami1, Kei Masuda1, Tsukasa Oda2, Yuta Masuda1, Hikaru Hattori1, Rei Ishihara1, Kazuki Honma1, Saki Watanabe1, Yuko Kuroda1, Nobuhiko Kobayashi3, Takayuki Saitoh1, Hirono Iriuchishima5, Hiromi Koiso3, Takuma Ishizaki3, Hiroaki Shimizu3, Yohei Osaki4, Akihiko Yokohama5, Norifumi Tsukamoto4, Nanami Gotoh1, Tetsuhiro Kasamatsu1, Hirokazu Murakami1, Hiroshi Handa3 (1.Graduate School of Health Sciences, Gunma University, Gunma, Japan, 2.Institute for Molecular and Cellular Regulation, Gunma University, Gunma, Japan, 3.Department of Hematology, Gunma University, Gunma, Japan, 4.Oncology Center, Gunma University Hospital, Gunma, Japan, 5.Blood Transfusion Service, Gunma University Hospital, Gunma, Japan)
Mitsuhito Hirano1, Yoichi Imai2, Wengchif Ung1, Kota Sato3, Muneyoshi Futami1,2, Arinobu Tojo1,2 (1.Division of Molecular Therapy, IMSUT, 2.Department of Hematology/Oncology, IMSUT hospital, 3.Department of Hematology Japanese Red Cross Medical Center)
Ariunzaya Bat-Erdene1, Takeshi Harada1, Masami Iwasa1, Asuka Oda1, Shiro Fujii1, Kimiko Sogabe1, Shingen Nakamura1, Jumpei Teramachi2, Masahiro Hiasa3, Hirofumi Tenshin3, Mohannad Ashtar3, Kotaro Tanimoto3, Hirokazu Miki4, Mamiko Takahashi1, Masahiro Oura1, Kumiko Kagawa1, Masahiro Abe1 (1.Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School of Medicine, Tokushima, Japan, 2.Department of Tissue Regeneration, Tokushima University, Tokushima, Japan, 3.Department of Orthodontics and Dentofacial Orthopedics, Tokushima University Graduate School of Oral Sciences, Tokushima, Japan, 4.Division of Transfusion Medicine and Cell therapy, Tokushima University, Tokushima, Japan)
Mohannad Ashtar1,2, Hirofumi Tenshin1,2, Jumpei Teramachi2,3, Masahiro Hiasa1,2, Kotaro Tanimoto1,2, Asuka Oda2, Masami Iwasa2, Takeshi Harada2, Bat Erdene Ariunzaya2, Kimiko Sogabe2, Masahiro Oura2, Shiro Fujii2, Kumiko Kagawa2, Shingen Nakamura2, Hirokazu Miki4, Eiji Tanaka1, Toshio Matsumoto5, Masahiro Abe2 (1.Department of Orthodontics and Dentofacial Orthopedics, Tokushima University, 2.Department of Hematology, Endocrinology and Metabolism, Tokushima University, 3.Department of Tissue Regeneration, Tokushima University, 4.Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, 5.Fujii Memorial Institute of Medical Sciences, Tokushima University)